⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Leidos Holdings LDOS

United States Technology
5.9/10
AI Analyst score
123.61 USD
Last price at analysis date · analyst target 157.27 (+27.2%)
🛒 Where to buy LDOSPartner brokers · US (NYSE/Nasdaq) · sample 200.00 € orderUS (NYSE/Nasdaq)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold; the cheap valuation and business quality offset weak growth, but wait for an improvement in momentum or earnings growth before adding to the position.

Leidos Holdings is a technology and information services company that provides defense, intelligence, health, and civil security solutions to U.S. government agencies, primarily under long-term contracts. Leidos shows acceptable financial health (Net Debt/EBITDA 2.45) and solid quality (ROE 27.78%), but its earnings growth is negative (-6.70%) and momentum is weak (score 2.74). Valuation is attractive (P/E 11.55, FCF yield 7.39%), suggesting the market already discounts these weaknesses.

Financial health
5.4
Quality / Moat
6.1
Valuation
7.4
Growth
4.5
Dividend
4.8
Momentum
2.7
Risk & Context
7.7

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E11.55
Fwd P/E9.69
EV/EBITDA8.98
P/B2.94
P/S0.88
PEG2.46
Market cap15.51 B USD
Enterprise value21.39 B USD
🏰 Quality and moat
ROIC (approx.)17.4%
Gross margin17.79%
FCF conversion48%
Operating margin11.72%
📈 Profitability and margins
ROE27.78%
ROA8.91%
Net margin7.80%
FCF1.15 B USD
FCF yield7.39%
🏦 Solvency and liquidity
Total debt6.58 B USD
Net debt5.83 B USD
Cash748.0 M USD
EBITDA2.38 B USD
Net debt / EBITDA2.45
D/E123.28
Current ratio1.63
Quick ratio1.15
🚀 Growth
Revenue growth7.20%
Earnings growth-6.70%
EPS (TTM)10.70 USD
EPS (Fwd)12.75 USD
💰 Dividend and risk
Dividend yield1.39%
Payout15.8%
Beta0.57
Analyst consensusBuy (15)
Target price157.27 USD
52-week range98.86 USD – 205.77 USD
⚠️ Main risk: The main risk is dependence on U.S. government contracts, subject to federal budget volatility and potential award delays, which is already reflected in negative earnings growth.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Leidos Holdings is a technology and information services company that provides defense, intelligence, health, and civil security solutions to U.S. government agencies, primarily under long-term contracts. Leidos shows acceptable financial health (Net Debt/EBITDA 2.45) and solid quality (ROE 27.78%), but its earnings growth is negative (-6.70%) and momentum is weak (score 2.74). Valuation is attractive (P/E 11.55, FCF yield 7.39%), suggesting the market already discounts these weaknesses.

Score by category

CategoryScore
Financial health5.4
Quality / Moat6.1
Valuation7.4
Growth4.5
Dividend4.8
Momentum2.7
Risk & Context7.7

OVERALL SCORE: 5.9/10

Context and risks

Leidos operates in the U.S. defense sector, where spending is subject to budget cycles and fiscal policy. The rise in 10-year Treasury yields (5.17%) makes financing more expensive for a business with Net Debt/EBITDA of 2.45, although its long-term government contract backlog mitigates interest rate risk.

News considered in the analysis

  • Leidos Holdings (LDOS) Lands Army Contract, Is The Stock Trading Below Fair Value? — La adjudicación de un contrato del Ejército es positiva, pero es un hecho recurrente en su modelo de negocio y su magnitud no se detalla; el mercado ya lo descuenta parcialmente.
  • How Much Higher Can Planet Labs Stock Go From Here? — Artículo sobre otra empresa (Planet Labs), sin información relevante para Leidos.
  • Leidos (LDOS) Suffers a Larger Drop Than the General Market: Key Insights — La caída mayor que el mercado refleja el momentum negativo ya capturado en la nota de Momentum (2.74); no aporta información fundamental nueva.
  • US Running Low on the 2 Weapons It Would Need Most — La posible escasez de armamento podría traducirse en mayores pedidos para contratistas de defensa como Leidos, pero es especulativo y no está confirmado.
  • 2 Industrials Stocks to Consider Right Now and 1 That Underwhelm — Listículo genérico sin información específica y accionable sobre Leidos.

Verdict: Hold; the cheap valuation and business quality offset weak growth, but wait for an improvement in momentum or earnings growth before adding to the position.

Main risk: The main risk is dependence on U.S. government contracts, subject to federal budget volatility and potential award delays, which is already reflected in negative earnings growth.

Other Technology companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.